State health labs in the US have received government funding to purchase sequencers from companies such as Illumina and Thermo Fisher Scientific’s Life Technologies. Congress aims to equip public health labs in all states with the ability to conduct whole genome sequencing for the detection and study of drug-resistant bacteria by 2018. Each year, antibiotic-resistant […]
The growing use of technologies in agriculture is helping turn farms into factories. Known as “precision farming” or “precision agriculture,” this evolving method of agriculture aims to increase productivity in farms while keeping costs low. Genome editing is a key aspect of precision farming, as it is used to develop an understanding of the genomic […]
For the first time in 40 years, the US Toxic Substances Control Act (TSCA) has been revised, with the new law making it simpler for the EPA to regulate harmful chemicals. Since the creation of the TSCA in 1976, the EPA has regulated only five chemicals, likely due to the limited amount of time the […]
In 2015, spending on cancer medicines reached $107 billion, an 11.5% increase in constant dollars. Globally, over 500 companies are focusing on oncology development, with 511 companies pursuing a Late Phase active pipeline and 379 firms with drugs in Phase II development. Of the 511 companies, oncology drug development made up 49% of collective R&D. […]
Last month, the US government launched the public-private National Microbiome Initiative (NMI) to research microbiomes in different ecosystems. The three recommended areas of focus are: interdisciplinary research, to further understanding about the relationship between microbiomes and their ecosystems; platform technologies, to increase collaboration and access to research data; and workforce expansion, to encourage engagement in […]
In 2015, Pharmaceutical Research and Manufacturers of America (PhRMA) members invested an estimated $58.8 billion into biopharmaceutical R&D, a 10.3% increase from 2014. Last year, domestic R&D costs were 25% of domestic sales, an 8.8% increase to $40.5 billion, while total R&D costs were 20% of total sales, a 6.5% increase to $52.8 billion. In […]
According to a study assessing legislation and policies affecting International Higher Education (IHE) in 26 countries, Germany and Malaysia have the best policies supporting IHE. The results are based on rankings for three categories: openness of HE and support of international mobility for students, academics and university programs; quality assurance of international students, and recognition […]
Released last month, new data detailing federal research funding in the US indicates that combined funding for R&D and R&D Plant increased 4.1% in FY14 to $132.5 billion. FY15 funding for R&D and R&D Plant is expected to increase slightly to $132.8 billion, while FY16 funding is forecast to increase 5.8% to $140.5 billion. For […]
This month’s “Morbidity and Mortality Week Report” published by the Centers for Disease Control and Prevention (CDC) outlined how changes in culture-independent diagnostic tests (CIDTs) for foodborne illnesses aid physicians in identifying infections, but may be limited in monitoring and preventing diseases. FoodNet, an organization made up of the CDC, 10 state health departments, the […]
The USDA has decided to not regulate mushrooms that have been genetically modified using CRISPR-Cas9, making it the first CRISPR-edited crop that will be able to bypass the USDA’s regulations. It is the latest crop created with gene-editing techniques to not require USDA approval because it does not contain “plant pest” DNA. In fall 2015, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
